Placeholder text

RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF COMBINED DRUG IN BULK

RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF COMBINED DRUG IN BULK Medicine

RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF COMBINED DRUG IN BULK

0 - Default Title
Description
The studies lead to the conclusion that the estimation of Escitalopram (ESC) and Etizolam (ETI) in their combination dosage tablet formulations can be accomplished with success using the RP-HPLC technology. The RP-HPLC method is sensitive, accurate, precise, specific, and has good reliability. It is also possible to successfully analyse the combined dosage formulation of etizolam (ETI) and escalopram (ESC).With these methods, there is no interference from additives, matrices, etc. These investigations could be clarified with additional research on different pharmacological formulations. The suitability of these methods on biological samples needs to be studied in the future.
Product details
Binding:
Paperback
Number of Pages:
108
Release Date:
2025-04-30
Publication Date:
2025-04-30
Publisher:
LAP LAMBERT Academic Publishing
Languages:
Original: English
ISBN10:
6208433703
ISBN13:
9786208433703
GPSR Manufacturer Reference:
Weight:
179 g
Height:
150 cm
Width:
220 cm
Thickness:
8 cm
Currently sold out